Literature DB >> 22263711

Opioid agonist maintenance for probationers: patient-level predictors of treatment retention, drug use, and crime.

Jan Gryczynski1, Timothy W Kinlock, Sharon M Kelly, Kevin E O'Grady, Michael S Gordon, Robert P Schwartz.   

Abstract

This study examined outcomes and their predictors among 181 probationers enrolling in opioid agonist maintenance with methadone or levo-alpha-acetylmethadol (LAAM). Participants were interviewed at treatment entry and 2-, 6-, and 12-month follow-ups. Treatment retention and frequency of heroin use, cocaine use, and income-generating criminal activity were examined using survival and longitudinal analyses. Participants reported marked reductions in drug use and crime relative to treatment entry. A number of patient characteristics associated with various outcomes were identified. The findings support engaging probationers in treatment and highlight patient factors that might influence outcomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22263711     DOI: 10.1080/08897077.2011.616816

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  22 in total

1.  Treatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status.

Authors:  Shannon Gwin Mitchell; Jan Gryczynski; Sharon M Kelly; Kevin E O'Grady; Jerome H Jaffe; Yngvild K Olsen; Robert P Schwartz
Journal:  J Drug Issues       Date:  2014-01

2.  Methadone treatment for HIV prevention-feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: a retrospective cohort study.

Authors:  Barrot H Lambdin; Frank Masao; Olivia Chang; Pamela Kaduri; Jessie Mbwambo; Ayoub Magimba; Norman Sabuni; R Douglas Bruce
Journal:  Clin Infect Dis       Date:  2014-05-22       Impact factor: 9.079

3.  Adherence to and Retention in Medications for Opioid Use Disorder Among Adolescents and Young Adults.

Authors:  Adam Viera; Daniel J Bromberg; Shannon Whittaker; Bryan M Refsland; Milena Stanojlović; Kate Nyhan; Frederick L Altice
Journal:  Epidemiol Rev       Date:  2020-01-31       Impact factor: 6.222

4.  U.S. Department of Veterans Affairs Veterans Justice Outreach Program: Connecting Justice-Involved Veterans with Mental Health and Substance Use Disorder Treatment.

Authors:  Andrea K Finlay; David Smelson; Leon Sawh; Jim McGuire; Joel Rosenthal; Jessica Blue-Howells; Christine Timko; Ingrid Binswanger; Susan M Frayne; Janet C Blodgett; Tom Bowe; Sean C Clark; Alex H S Harris
Journal:  Crim Justice Policy Rev       Date:  2013-12-18

5.  Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts.

Authors:  Robert P Schwartz; Sharon M Kelly; Kevin E O'Grady; Shannon Gwin Mitchell; Barry S Brown
Journal:  Drug Alcohol Depend       Date:  2010-12-03       Impact factor: 4.492

6.  Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections.

Authors:  Peter D Friedmann; Donna Wilson; Hannah K Knudsen; Lori J Ducharme; Wayne N Welsh; Linda Frisman; Kevin Knight; Hsiu-Ju Lin; Amy James; Carmen E Albizu-Garcia; Jennifer Pankow; Elizabeth A Hall; Terry F Urbine; Sami Abdel-Salam; Jamieson L Duvall; Frank J Vocci
Journal:  J Subst Abuse Treat       Date:  2014-10-14

7.  Sex differences in mental health and substance use disorders and treatment entry among justice-involved Veterans in the Veterans Health Administration.

Authors:  Andrea K Finlay; Ingrid A Binswanger; David Smelson; Leon Sawh; Jim McGuire; Joel Rosenthal; Jessica Blue-Howells; Christine Timko; Janet C Blodgett; Alex H S Harris; Steven M Asch; Susan Frayne
Journal:  Med Care       Date:  2015-04       Impact factor: 2.983

8.  Justice Involvement and Treatment Use Among Rural Veterans.

Authors:  Andrea K Finlay; Alex H S Harris; Joel Rosenthal; Jessica Blue-Howells; Sean Clark; Bessie Flatley; Christine Timko
Journal:  Rural Ment Health       Date:  2018-01

9.  Improvements in outcomes in methadone patients on probation/parole regardless of counseling early in treatment.

Authors:  Sharon M Kelly; Kevin E Oʼgrady; Jerome H Jaffe; Devang Gandhi; Robert P Schwartz
Journal:  J Addict Med       Date:  2013 Mar-Apr       Impact factor: 3.702

10.  Leaving buprenorphine treatment: patients' reasons for cessation of care.

Authors:  Jan Gryczynski; Shannon Gwin Mitchell; Jerome H Jaffe; Kevin E O'Grady; Yngvild K Olsen; Robert P Schwartz
Journal:  J Subst Abuse Treat       Date:  2013-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.